World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
26683
World Ranking
17910
National Ranking
40

Overview

Glenda Gray is affiliated with the South African Medical Research Council in South Africa and has a significant body of work primarily within the field of Medicine. Their research spans multiple subfields including Infectious Diseases, Epidemiology, Virology, Health, and Molecular Biology. The main topics addressed in their work include SARS-CoV-2 and COVID-19 research, HIV/AIDS research and interventions, HIV research and treatment, vaccine coverage and hesitancy, COVID-19 clinical research studies, adolescent sexual and reproductive health, and vaccines and immunoinformatics approaches.

The scientist has contributed to various frequent publication venues, reflecting their active engagement with both specialized and broad scientific communities. These venues include bioRxiv (Cold Spring Harbor Laboratory), South African Medical Journal, UNC Libraries, New England Journal of Medicine, and Scientific Reports.

Among their recent papers are several influential works:

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19, 2021, New England Journal of Medicine
  • T cell responses to SARS-CoV-2 spike cross-recognize Omicron, 2022, Nature
  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition, 2021, New England Journal of Medicine
  • COVID-19 in Africa: care and protection for frontline healthcare workers, 2020, Globalization and Health
  • Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa, 2021, International Journal of Infectious Diseases

Glenda Gray has collaborated extensively with several researchers, with notable frequent coauthors including Linda-Gail Bekker, Lawrence Corey, Nigel Garrett, James G. Kublin, and Peter B. Gilbert. These collaborations indicate strong connections within the fields of infectious disease research and clinical studies.

Their research contributions are built on a foundation of investigating vaccine efficacy, HIV treatment innovations, and COVID-19 disease dynamics, highlighting a career deeply involved in addressing public health challenges through clinical and molecular research methodologies.

Best Publications

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

    Jerald Sadoff;Glenda Gray;An Vandebosch;Vicky Cárdenas

  • Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

    C. Celum;A. Wald;A. Wald;J.R. Lingappa;A.S. Magaret;A.S. Magaret

  • COVID-19 in Africa: care and protection for frontline healthcare workers.

    Matthew F. Chersich;Glenda Gray;Lee Fairlie;Quentin Eichbaum;Quentin Eichbaum

  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

    Lawrence Corey;Peter B Gilbert;Michal Juraska;David C Montefiori

  • Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

    Glenda E. Gray;Mary. Allen;Zoe. Moodie;Gavin J. Churchyard

  • New Regimens to Prevent Tuberculosis in Adults with HIV Infection

    Neil A. Martinson;Grace L. Barnes;Lawrence H. Moulton;Reginah Msandiwa

  • Prevalence and Patterns of Gender-based Violence and Revictimization among Women Attending Antenatal Clinics in Soweto, South Africa

    Kristin L. Dunkle;Rachel K. Jewkes;Heather C. Brown;Mieko Yoshihama

  • International Seroepidemiology of Adenovirus Serotypes 5, 26, 35, and 48 in Pediatric and Adult Populations

    Dan H. Barouch;Dan H. Barouch;Sandra V. Kik;Gerrit J. Weverling;Rebecca Dilan

  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh

  • Community-based intervention to increase HIV testing and case detection in people aged 16–32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study

    Michael Sweat;Stephen Morin;David Celentano;Marta Mulawa

  • Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.

    Jonathan E Golub;Paul Pronyk;Paul Pronyk;Lerato Mohapi;Nkeko Thsabangu

  • Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection

    Karin Nielsen-Saines;D. Heather Watts;Valdilea G. Veloso;Yvonne J. Bryson

  • Emergence of Drug-Resistant HIV-1 after Intrapartum Administration of Single-Dose Nevirapine Is Substantially Underestimated

    Jeffrey A. Johnson;Jin Fen Li;Lynn Morris;Neil Martinson

  • Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+ T Cells: Correlation with Viral Load

    Agatha Masemola;Tumelo Mashishi;Greg Khoury;Phineas Mohube

  • Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine.

    Glenda Gray;Susan Buchbinder;Ann Duerr

  • The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients.

    Amalia Rodriguez-French;Jack Boghossian;Glenda E Gray;Jeffrey P Nadler

  • Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

    Jairam R Lingappa;Jared M Baeten;Anna Wald;James P Hughes

  • Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa

    Milly Marston;Renaud Becquet;Renaud Becquet;Basia Zaba;Lawrence H. Moulton

  • Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.

    Timothy B. Hallett;Jared M. Baeten;Renee Heffron;Ruanne Barnabas

  • Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk

    Jairam R. Lingappa;James P. Hughes;Richard S. Wang;Jared M. Baeten

Frequent Co-Authors

Janan Dietrich
Janan Dietrich South African Medical Research Council
Linda-Gail Bekker
Linda-Gail Bekker University of Cape Town
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
James G. Kublin
James G. Kublin Fred Hutchinson Cancer Research Center
Lynn Morris
Lynn Morris University of the Witwatersrand
Angela Kaida
Angela Kaida Simon Fraser University
Helen Rees
Helen Rees University of the Witwatersrand
Linda Richter
Linda Richter University of the Witwatersrand
M. Juliana McElrath
M. Juliana McElrath University of Washington
Robert S. Hogg
Robert S. Hogg Simon Fraser University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their medical education, numerous online degree options and career pathways are available across the healthcare spectrum. If you’re looking to grow your nursing expertise quickly, consider accelerated dnp programs, which allow you to earn your doctorate in nursing at a faster pace than traditional paths.

Budget-conscious students might look into affordable dnp programs, focusing on courses that combine quality education with cost-effectiveness. Practical nursing candidates can opt for fast track lpn programs online, which help you enter the workforce swiftly or continue your studies toward higher qualifications without delay.

Registered nurses interested in mental health specialization can pursue bsn to np programs online focused specifically on psychiatric and mental health, setting the stage for advanced practice roles in this growing field. Exploring these programs can open diverse and flexible opportunities within the U.S. healthcare system.

Best Scientists Citing Glenda Gray

Trending Scientists